Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Total article views   HTML views PDF downloads Totals
14,491 Dovepress* 13,119+ 2,271 15,390
PubMed Central* 1,372 668 2,040
Totals 14,491 2,939 17,430
*Since 14 September 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed Central and Google Scholar